Balchem
Open
$164.83
Prev. Close
$164.82
High
$165.23
Low
$164.82
Market Snapshot
$5.29B
33.4
3.97
$953.68M
Balchem Corp. markets specialty performance ingredients and products. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp. markets specialty performance ingredients and products. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Recently from Cashu
Balchem (BCPC) Time-Stamps Q4 Earnings Disclosure for Feb. 20, 2026, 7:12 a.m. ET
Balchem time-stamps Q4 earnings disclosure Balchem Inc. is today issuing a time-stamped notice that it discloses fourth-quarter results on Feb. 20, 2026 at 07:12 a.m. ET, using the NASDAQ ticker BCPC…
Balchem Earnings Preview: Margins, Market Demand, Cash Flow and Product Pipeline
Earnings preview: Balchem faces scrutiny on margins and market demand Balchem is preparing to publish its quarterly results on Feb. 20, 2026, with attention concentrated on margins and demand trends a…
Balchem Q4 Release Feb. 20: Margins, Guidance, Capital Allocation in Focus
Balchem Flags Q4 Disclosure, Eyes on Operational Drivers Balchem schedules its fourth-quarter earnings release for Feb. 20, 2026 at 07:12 a.m. ET, setting up a company update that centres on operation…
Balchem's Element Solutions Set for Growth Amidst Specialty Chemicals Demand and Innovation
Element Solutions Poised for Growth Amidst Specialty Chemicals Demand Element Solutions is gearing up to unveil its quarterly earnings report on October 28, 2025, amidst a promising backdrop of growth…